Irresponsible politicians are pushing America toward terrible policy choices, like importing drug-price controls from Canada and limiting patent authority.

This book comprises ten papers and a panel discussion on public policies toward the pharmaceutical research and development process.

New research findings and a thorough reassessment of older research indicate that drugs like Vioxx can have many important benefits and great potential for addressing serious problems.

Government reimbursement programs often create cross-subsidies and other distortions that greatly complicate the task of setting reasonable and efficient reimbursement levels.

We have a pharmaceutical research and development system that really works.

John E. Calfee and Merrill Goozner debate the question of how much the government can and should do about the cost of medicines, now and in the future.

Reports from AARP and Families USA have heightened concerns among policymakers and the public about the affordability of prescription drugs. However, those reports are misleading.

The world’s poor and those in need of medicines would be better off if the WHO took different approaches to pharmaceutical development.